Lunedì 18 ottobre 2021

Programma preliminare della giornata

AUDITORIUM RITA LEVI MONTALCINI

8:00 - 9:00 | DIBATTITO CASE BASED: TUMORE DELLA VESCICA NIMBC HG: UN UPDATE

Moderatori: M. Brausi (Modena), R. Naspro (Bergamo)

  • È GIUNTO IL MOMENTO DELL’IMMUNOTERAPIA SISTEMICA?
    A. Necchi (Milano)
  • T1G3 BCG FAILURE NELL’ANZIANO: QUALI STRATEGIE OGGI?
    R.L. Schips (Chieti)
  • RISONANZA MAGNETICA NELLA STADIAZIONE DEI NMIBC
    A. Messina (Milano)
  • DISCUSSIONE
9:00 - 10:00 | TAVOLA ROTONDA: MUTAZIONI SOMATICHE E GERMINALI NEI TUMORI UROLOGICI: QUANDO ESEGUIRE I TEST GENETICI?
10:00 - 10:15 | UROWORLD BREAKING NEWS: PATOLOGIA BENIGNA (DAI CONGRESSI, DALLA LETTERATURA, DALLE AZIENDE)
10:15 - 11:15 | SESSIONE SIU EULIS: THE LIFE OF A STONE CENTER IN COVID AND “POST” COVID ERA: WHAT WE LEARNED FROM PANDEMIC
11:15- 11:30 | SIMULAZIONE IN UROLOGIA DAL PROGETTO SIMBASE AL SISE/EAU
11:30 - 12:00 | CONSORZIO INTERSOCIETARIO: A CHE PUNTO SIAMO
12:00 - 13:00 | HOT SPOTS IN ANDROLOGIA
14:00 - 14:45 | DIBATTITO: NUOVE TECNOLOGIE - NEW TECHNOLOGIES SESSION
14:45 - 16:00 | VIDEO-DIBATTITO: L'ESPERTO ALL'OPERA E NUOVE TECNOLOGIE NELLA PRATICA CLINICA
16:00 - 17:00 | TAVOLA ROTONDA: L’INCONTINENZA: DALLA TERAPIA MEDICA ALLA PROTESICA
17:00 - 17:25 | LETTURA: ARISTOCRAZIA 2.0
17:30 - 19:00 | ASSEMBLEA GENERALE

SALA CAMILLO GOLGI

8:00 - 9:15 | SMART COMMUNICATION/VIDEO (SC189-SC196/V10): BPH: TREATMENT BEYOND LASER

Moderatori: R. Leonardi (Catania), A. Rizzotto (Viterbo)

  • SC189 HOLMIUM LASER ENUCLEATION OF PROSTATE VERSUS MINIMALLY INVASIVE SIMPLE PROSTATECTOMY FOR LARGE VOLUME (≥ 120 ML) PROSTATE GLANDS: A PROSPECTIVE MULTICENTER RANDOMIZED STUDY
    A.L. Pastore, A. Fuschi, Y. Al Salhi, A. Martoccia, L. Capone, P.P. Suraci, S. Scalzoi, F.M. Valenzi, A. Antonioni, O.A. Rera, F. Annino, G. Bozzini, M. Falsaperla, A. Carbone (Latina)
  • SC190 EXTERNAL VALIDATION OF PATIENT-MEASURED OUTCOMES FOR ROBOT-ASSISTED SIMPLE PROSTATECTOMY: A COMPARISON OF DIFFERENT SURGICAL TECHNIQUES ACCORDING TO BPH6 INDEX
    U. Anceschi, A. Brassetti, G. Tuderti, R. Mastroianni, A.M. Bove, M.C. Ferriero, L. Misuraca, G. Simone (Roma)
  • SC191 FUNCTIONAL AND SEXUAL SYMPTOMS IMPROVEMENT AFTER REZUM WATER VAPOR THERAPY FOR THE TREATMENT OF LUTS/BPE: 1-YEAR RESULTS FROM A LONGITUDINAL MULTI-CENTER ITALIAN STUDY
    A. Cocci, G.I. Russo, F. Sessa, A. Tuccio, L. Masieri, S. Sforza, L. Viola, G. Cito, J.I. Martinez Salamanca, L. Cindolo, G. Ferrari, G. Siena (Firenze)
  • SC192 PRELIMINARY EXPERIENCE WITH TEMPORARY SILICONE URETHRAL STENTS AS AN ALTERNATIVE TO INDWELLING CATHETER IN PATIENTS WAITING FOR BENIGN PROSTATIC HYPERPLASIA SURGERY
    M. Sibona, P. Destefanis, F. Vitiello, E. Vercelli, G. Montefusco, A. Bosio, A. Bisconti, P. Gontero (Torino)
  • SC193 REAL-WORLD OUTCOMES OF PROSTATIC URETHRAL LIFT (PUL) IN SUBJECTS WITH OBSTRUCTIVE MEDIAN LOBES REINFORCES PUL AS AN EFFECTIVE TREATMENT FOR ALL TYPES OF PROSTATE ENLARGEMENT
    M. Rochester, N. Barber, G. Eure, D. Grier (Norwich)
  • SC194 PREDICTORS OF DURABILITY AFTER PROSTATIC URETHRAL LIFT IN THE REALWORLD AND LIFT CONTROLLED TRIAL
    M. Rochester, C. Roehrborn, N. Barber, G. Eure, P. Chin, D. Grier (Norwich)
  • SC195 PROSTATIC ARTERY EMBOLIZATION VERSUS TRANSURETHRAL RESECTION OF THE PROSTATE: ASSESSMENT OF SAFETY AND EFFICACY
    T. Di Vico, I. Meneghetti, L. Mosillo, A. Piccirilli, C. Catalano, L. Lorenzi, V. Vocatur (Massa)
  • SC196 PROSTATIC ARTERIAL EMBOLIZATION AS A MICRO-INVASIVE ALTERNATIVE TREATMENT OF BENIGN PROSTATIC OBSTRUCTION: OUTCOMES ANALYSIS UNDER A UROLOGICAL POINT OF VIEW
    S. Minucci, R. Bertolo, M.S. Giuliani, C. Cipriani, F. Maiorino, M. Vittori, V. Iacovelli, F. Petta, M. Panei, P. Bove (Roma)
  • V10 TRANSVESCICAL ROBOTIC ASSISTED SIMPLE PROSTATECTOMY (RASP): OUR TECHNIQUE AND EARLY PERIOPERATIVE RESULTS
    G. Patruno, P. Pacini, A. Cardi, F.E. D’Amico, G. Tuffu, A. De Vico, G. D’Elia (Roma)
9:15 - 10:30 | SMART COMMUNICATION/VIDEO (SC228-SC235/V12-V13): TESTICULAR AND PENILE CANCER
10:30 - 12:00 | VIDEO (V14-V21): ROBOTIC PARTIAL NEPHRECTOMY
13:00 - 14:00 | SIMPOSIO: IL VALORE DEL TEMPO NEL PAZIENTE CON CA AVANZATO ALLA PROSTATA
14:30 - 15:45 | SMART COMMUNICATION (SC244-SC253): DIAGNOSIS AND STAGING OF UROTHELIAL CARCINOMA
15:45 - 16:45 | SMART COMMUNICATION (SC266-SC273): ACTIVE SURVEILLANCE FOR LOCALISED PROSTATE CANCER

SALA RENATO DULBECCO

8:00 - 9:15 | SMART COMMUNICATION (SC197-SC207): RECURRENT AND METASTATIC PROSTATE CANCER

Moderatori: A. Bosio (Torino), G. Simone (Roma)

  • SC197 WHAT IS THE OPTIMAL DURATION OF HORMONAL TREATMENT DURING SALVAGE RADIOTHERAPY IN MEN WITH PN1 PROSTATE CANCER? RESULTS FORM A LARGE MULTI-INSTITUTIONAL SERIES
    D. Cannoletta, N. Fossati, R.J. Karnes, S.A. Boorjan, G. Motterle, A. Bossi, T. Kumar, N. Di Muzio, C. Cozzarini, B. Noris Chiorda, G. Gandaglia, A. Stabile, V. Cucchiara, D. Robesti, D. Bartkowiak, S. Shariat, G. Goldner, S. Joniau, H. Van Poppel, C. Berghen, G. De Meerleer, F. Montorsi, T. Wiegel, A. Briganti (Milano)
  • SC198 ASSESSING THE EFFECT OF CONCOMITANT HORMONAL THERAPY ON SEVERE TOXICITY IN PATIENTS TREATED WITH POST-PROSTATECTOMY RADIATION THERAPY: RESULTS FROM A LARGE, MULTI-INSTITUTIONAL STUDY
    N. Fossati, E. Mazzone, R.J. Karnes, S.A. Boorjan, G. Motterle, A. Bossi, T. Kumar, N. Di Muzio, C. Cozzarini, B. Noris Chiorda, G. Gandaglia, A. Stabile, V. Cucchiara, S. Scuderi, D. Robesti, D. Bartkowiak, S. Shariat, G. Goldner, S. Joniau, H. Van Poppel, C. Berghen, G. De Meerleer , F. Montorsi, T. Wiegel, A. Briganti (Milano)
  • SC199 THERE IS NO WAY TO COMPENSATE A NON-TIMELY USE OF EARLY SALVAGE RADIATION THERAPY IN MEN WITH RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY. A RETROSPECTIVE, MULTI-CENTRE ANALYSES ON ONCOLOGICAL AND TOXICITY OUTCOMES
    E. Mazzone, N. Fossati, R.J. Karnes, S.A. Boorjan, G. Motterle, A. Bossi, T. Kumar, N. Di Muzio, C. Cozzarini, B. Noris Chiorda, G. Gandaglia, A. Stabile, S. Scuderi, D. Bartkowiak, S. Shariat, G. Goldner, S. Joniau, H. Van Poppel, C. Berghen, G. De Meerleer, F. Montorsi, T. Wiegel, A. Briganti (Milano)
  • SC200 VERY LONG TERM OUTCOMES, TIME PATTERNS OF RECURRENCE AND OTHERCAUSE MORTALITY IN PATIENTS TREATED WITH SALVAGE RADIATION THERAPY FOR RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY: IMPLICATIONS FOR RISK TAILORED FOLLOW-UP STRATEGIES
    C. Giuseppe, N. Fossati, A. Stabile, A. Martini, R.J. Karnes, S.A. Boorjan, A. Bossi, N. Di Muzio, C. Cozzarini, G. Gandaglia, D. Bartkowiak, D. Böhmer, S. Shariat, G. Goldner, G. Devos, S. Joniau, C. Berghen, G. De Meerleer , H. Van Poppel, A. Necchi, F. Montorsi, T. Wiegel, A. Briganti (Milano)
  • SC201 THE KEY ROLE OF PSA DOUBLING TIME IN PATIENTS TREATED WITH SALVAGE RADIATION THERAPY AFTER RADICAL PROSTATECTOMY: IMPLICATIONS FOR THE EXTENT OF RADIATION AND THE CONCOMITANT USE OF HORMONAL THERAPY
    F. Nicola, R.J. Karnes, S.A. Boorjan, G. Motterle, A. Bossi, T. Kumar, N. Di Muzio, C. Cozzarini, B. Noris Chiorda, E. Mazzone, G. Gandaglia, D. Robesti, D. Bartkowiak, S. Shariat, G. Goldner, S. Joniau, H. Van Poppel, C. Berghen, G. De Meerleer, F. Montorsi, T. Wiegel, A. Briganti (Milano)
  • SC202 IDENTIFYING THE MOST INFORMATIVE CUT-OFF OF PSA TO DEFINE BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: A STAGE-BY-STAGE ANALYSIS
    L. Nocera, G. Gandaglia, N. Fossati, A. Stabile, V. Cucchiara, E. Mazzone, C.A. Bravi, G. Rosiello, G. Sorce, F. Pellegrino, S. Scuderi, F.M. Barletta, G. Cirulli, R. Colombo, A. Salonia, F. Montorsi, A. Briganti (Milano)
  • SC203 IMPACT OF POSTOPERATIVE RADIOTHERAPY ON BIOCHEMICAL RECURRENCE IN PN1 PROSTATE CANCER PATIENTS: ESTABLISHING THE MOST APPROPRIATE TIMING FOR RADIOTHERAPY ADMINISTRATION
    F.A. Mistretta, I. Sabatini, G. Marvaso, S. Luzzago, M. Catellani, E. Di Trapani, G. Corrao, G. Cozzi, R. Bianchi, M. Augugliaro, G. Cordima, M. Ferro, D. Bottero, D.V. Matei, G. Musi, B.A. Jereczek-Fossa, O. de Cobelli (Milano)
  • SC204 DEFINITION AND IMPACT ON ONCOLOGIC OUTCOMES OF PERSISTENTLY ELEVATED PSA AFTER SALVAGE LYMPH NODE DISSECTION FOR NODE-ONLY RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY: CLINICAL IMPLICATIONS FOR MULTI-MODAL THERAPY
    S. Scuderi, N. Fossati, G. Gandaglia, G. Motterle, R.J. Karnes, D. Pfister, A. Heidenreich, A. Kretschmer, A. Buchner, C. Stief, G. Devos, S. Joniau, H. Van Poppel, D. Osmonov, K. Jueneman, B. Grubmuller, S. Shariat, A. Hiester, P. Albers, D. Tilki, M. Graefen, I.S. Gill, A. Mottrie, C. Bravi, F. Montorsi, A. Briganti (Milano)
  • SC205 THE IMPACT OF LOCOREGIONAL TREATMENTS FOR METASTATIC CASTRATION RESISTANT PROSTATE CANCER ON DISEASE PROGRESSION: A REAL LIFE EXPERIENCE FROM A MULTICENTER COHORT
    M. Ferriero, C. De Nunzio, R. Mastroianni, G. Tuderti, U. Anceschi, L. Misuraca, A. Brassetti, S. Guaglianone, A.M. Bove, G. Tema, S. Giacinti, F. Calabrò, L. Cindolo, L. Schips, A. Tubaro, M. Gallucci, G. Simone (Roma)
  • SC206 THE OBESITY PARADOX IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER
    G.O. Cirulli, A. Martini, G. Gandaglia, N. Fossati, A. Necchi, D. Raggi, A. Stabile, V. Cucchiara, R. Leni, D. Robesti, F. Pellegrino, L. Nocera, S. Scuderi, P.I. Karakiewicz, M.D. Galsky, W.K. Oh, J.P. Sfakianos, A.B. Parikh, C. Tsao, F. Montorsi, A. Briganti (Milano)
  • SC207 WHICH PATIENTS WITH OLIGOMETASTATIC PROSTATE CANCER SHOULD BE CONSIDERED FOR CYTOREDUCTIVE RADICAL PROSTATECTOMY AS PART OF A MULTIMODAL TREATMENT? RESULTS FROM A LARGE, MULTI-INSTITUTIONAL COLLABORATION
    S. Scuderi, E. Mazzone, A. Heidenreich, G. Gandaglia, D. Pfister, S. Shariat, G. Bernhard, N. Fossati, G. Fallara, A. Pellegrino, R.J. Karnes, V. Cucchiara, C.A. Bravi, S. Scuderi, D. Robesti, R. Leni, D. Cannoletta, A. Gallina, M. Moschini, N. Suardi, A. Stabile, A. Necchi, F. Montorsi, A. Briganti (Milano)
9:15 - 10:15 | SMART COMMUNICATION (SC236-SC243): GENITO-URINARY INFECTIONS
11:30 - 13:00 | CORSO: RISONANZA MAGNETICA PROSTATICA: DALLA LETTURA ED INTERPRETAZIONE DELL’IMAGING ALLA BIOPSIA TARGET
13:00 - 14:00 | SIMPOSIO: LA MEDICINA DI PRECISIONE NEL MCRPC: UNA NUOVA ERA
14:30- 16:00 | SMART COMMUNICATION (SC254-SC265): PARTIAL NEPHRECTOMY - SURGICAL TECHNIQUE
16:00 - 17:30 | CORSO: NEOPLASIA DELL’UROTELIO QUALI NOVITÀ TERAPEUTICHE

SALA MARIO CAPECCHI

8:00 - 9:00 | SMART COMMUNICATION/VIDEO (SC208-SC213/V11): STONES - URETEROSCOPY

Moderatori: P. Aquati (Milano), M. Sighinolfi (Modena)

  • SC208 ALLIUM URETERAL STENT FOR THE TREATMENT OF URETERAL STRICTURE AND FISTULA AFTER ABDOMINAL SURGERY
    M. Sampalmieri, M. Di Marco, R. Parascani, A. Fraioli, C. Avitabile, F. Valenzi, G. Borgoni (Roma)
  • SC209 DIFFERENTIATED URETERAL DILATION TECHNIQUE AND ALLIUM STENT POSITIONING IN URETERO-PELVIC JUNCTION OBSTRUCTION RELAPSE
    G. Giusti, F. Petrucci, F. Di Cristofano, R. (Napoli), B. Tomasi, M. Lucci Chiarissi, A. De Lisa, S. Valerio, M.S. Mangano (Treviso)
  • SC210 COMPLICATIONS AND OUTCOMES OF LASER URETEROLITHOTRIPSY FOR URETERIC STONES: A MULTICENTRE ANALYSIS OF RISK FACTORS
    R. Lombardo, C. De Nunzio, M. Bellangino, L.M. Rovesti, A. Albano, R. Chacon, J. Lopez, M.P. Luque, M.J. Ribal, A. Alcaraz, A. Tubaro (Roma)
  • SC211 SIMULTANEOUS BILATERAL ENDOSCOPIC SURGERY (SBES): IS IT READY FOR PRIME TIME?
    M.P. Pavia, S. Proietti, L. Rico, M. Basulto-Martinez, Y. Yeow, L. Villa, E. Ventimiglia, A. Salonia, F. Gaboardi, G. Giusti (Milano)
  • SC212 URETEROSCOPY (URS) VIDEO CONSENSUS: A SIMPLE AND EFFECTIVE WAY TO IMPROVE AWARENESS OF PATIENTS UNDERGOING URS
    F. Esperto, F. Prata, A. Civitella, P. Tuzzolo, L. Romei, V.G. Crimi, F. Tedesco, T. Bach (Roma)
  • SC213 URETERAL THICKNESS AND DISTAL URETERAL DENSITY DO NOT PREDICT STONE FREE RATE IN PATIENTS TREATED WITH HO:LASER SEMI-RIGID URETEROLITHOTRIPSY
    A. Franco, C. De Nunzio, M. Bellangino, G. Tema, O.A. Voglino, A. Cremona, M. Pignatelli, A. Tubaro (Roma)
  • V11 TOTALLY INTRACORPOREAL ROBOT-ASSISTED ILEAL URETERIC REPLACEMENT FOLLOWING AN URETERAL INTUSSUSCEPTION
    R. Mastroianni, G. Tuderti, U. Anceschi, M. Ferriero, A. Brassetti, S. Guaglianone, M. Gallucci, G. Simone (Roma)
9:00 - 10:45 | SMART COMMUNICATION (SC214-SC227): PROSTATE CANCER - BIOPSY
13:00 - 13:30 | LETTURA: LE EVIDENZE SCIENTIFICHE DI SICUREZZA E AFFIDABILITÀ DELLE FORMULAZIONI LONG ACTING SEMESTRALI LHRHA
13:30 - 14:00 | LETTURA: TERAPIA MEDICA IPB: IL RUOLO CENTRALE DEGLI ALFA-LITICI NELLA PATIENT CENTERED MEDICINE
14:30 - 16:00 | CORSO: L’IMMUNOTERAPIA NEI TUMORI UROLOGICI: QUELLO CHE L’UROLOGO DEVE SAPERE
© 2021 designed by SGI